Elite Pharmaceuticals (ELTP) Other Accumulated Expenses (2019 - 2026)
Elite Pharmaceuticals (ELTP) reported Other Accumulated Expenses of $493,416 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 19.1% from $610,000 a year earlier and down 20.4% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Other Accumulated Expenses of $619,604, up 113.4% from FY2025.
- Other Accumulated Expenses has a four-year compound annual growth rate of -35.7% (FY2022 to FY2026).
- By fiscal year, Other Accumulated Expenses came in at $290,363 in FY2025 (-49.8%), $578,108 in FY2024 (-86.0%), $4.13 million in FY2023 (+13.8%) and $3.63 million in FY2022.
- Five-year quarterly Other Accumulated Expenses spans a low of $290,363 in fiscal Q4 2025 and a high of $6.93 million in fiscal Q3 2024.
- Year over year, Other Accumulated Expenses gained in four of the last eight quarters, with an average decline of 1.0%.
- The high point for year-over-year Other Accumulated Expenses in five years was fiscal Q4 2026 (growth of 113.4%); the low point was fiscal Q3 2025 (a decline of 95.4%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $619,604 (Q4 2026), $403,417 (Q3 2026) and $389,605 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 244.53 Mn | 126.20 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 493,416.00 |
| Mar 31, 2026 | 619,604.00 |
| Dec 31, 2025 | 403,417.00 |
| Sep 30, 2025 | 389,605.00 |
| Jun 30, 2025 | 610,000.00 |
| Mar 31, 2025 | 290,363.00 |
| Dec 31, 2024 | 318,513.00 |
| Sep 30, 2024 | 315,362.00 |
| Jun 30, 2024 | 324,265.00 |
| Mar 31, 2024 | 578,108.00 |
| Dec 31, 2023 | 6.93 Mn |
| Sep 30, 2023 | 6.41 Mn |
| Jun 30, 2023 | 4.47 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Mar 31, 2022 | 3.63 Mn |
| Dec 31, 2019 | 1.20 Mn |
API Access
Elite Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();